Clinical trial · Interventional
Computerized Cognitive Behavior Therapy in Treating Depression in Patients With Cancer
A Computerized Cognitive Behavioral Therapy for Cancer Patients With Major Depressive Disorder
NCT02837887CI-TRIAL-00045629completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This randomized clinical trial studies how well a computerized cognitive behavior therapy program works in treating depression in patients with cancer. The cognitive behavior therapy program uses a series of internet-delivered sessions intended to help patients identify and change problematic patterns of thinking and behavior that maintain depression.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Major Depressive Disorder | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Computerized Cognitive Behavior Therapy | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Group I (immediate treatment)
- description
- Patients undergo computerized cognitive behavior therapy consisting of 45-60 minute sessions once per week for 8 weeks. Patients also complete the PHQ-9 and GAD7 at weeks 1, 3, 5, 7 and 8 and complete other questionnaires for 15-30 minutes each that assess psychosocial and physical symptoms.
- interventionNames
- Behavioral: Computerized Cognitive Behavior Therapy
- type
- EXPERIMENTAL
- label
- Group II (wait-list)
- description
- Patients are placed on an 8-week wait-list and then undergo computerized cognitive behavior therapy and receive questionnaires as in Group I.
- interventionNames
- Behavioral: Computerized Cognitive Behavior Therapy
Primary outcomes (1)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * A current/prior cancer diagnosis * A principal diagnosis of major depressive disorder (MDD) * Able and willing to give informed consent * Have access to a computer with an internet connection at home Exclusion Criteria: * History of bipolar affective disorder or psychosis * History of substance dependence in the past six months * Subnormal intellectual potential (intelligence quotient \[IQ\] below 80) * Current suicide risk or significant intentional self-harm in the last six months sufficient to preclude treatment on an outpatient basis * Inability to read and write English
References
Publications (0)
Data not yet available
No reference posted for this study.